Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence

Clinical trial NCT03489265 · WITHDRAWN

Trial details

NCT number: NCT03489265
Sponsor: University of North Carolina, Chapel Hill
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fecal Incontinence Accidental Bowel Leakage Anal Incontinence Diarrhea Urge Incontinence

Start date: 2019-04-01
Primary completion: 2019-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.